Skip to main content
Oryzon Genomics S.A. (BME:ORY)
Spain flag Spain · Delayed Price · Currency is EUR
2.790
-0.022 (-0.78%)
Apr 28, 2026, 5:35 PM CET

Oryzon Genomics Revenue

In the year 2025, Oryzon Genomics had annual revenue of 10.93M EUR with 48.59% growth. Oryzon Genomics had revenue of 10.93M in the quarter ending December 31, 2025, with 48.59% growth.

Revenue
10.93M
Revenue Growth
+48.59%
P/S Ratio
19.93
Revenue / Employee
237.71K
Employees
46
Market Cap
217.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202510.93M3.58M48.59%
Dec 31, 20247.36M-6.83M-48.15%
Dec 31, 202314.19M-1.51M-9.60%
Dec 31, 202215.70M5.08M47.88%
Dec 31, 202110.62M1.09M11.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.52B
Laboratorios Farmaceuticos Rovi 743.48M
Almirall 1.11B
Pharma Mar 221.39M
Clínica Baviera 304.91M
Prim, S.A. 251.89M
Atrys Health 144.31M
Laboratorio Reig Jofre 336.68M
Revenue Rankings

Oryzon Genomics News

More News